01

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-30

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1278

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2026-08-30

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-16

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1515

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2033-08-16

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-30

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1278

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2026-08-30

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-16

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1515

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2033-08-16

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-08-16

LINACLOTIDE

US Patent Number : 9708371

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1516

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2033-08-16

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-10-30

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1516

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2031-10-30

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-10-30

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1515

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2031-10-30

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-08-30

LINACLOTIDE

US Patent Number : 7304036

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202811

Patent Use Code : U-1516

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2026-08-30

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-01-28

LINACLOTIDE

US Patent Number : 8110553

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1278

Patent Use Description : METHOD OF TREATING IRR...

Patent Expiration Date : 2024-01-28

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-10-30

LINACLOTIDE

US Patent Number : 8748573

Drug Substance Claim :

Drug Product Claim :

Application Number : 202811

Patent Use Code : U-1516

Patent Use Description : METHOD OF TREATING CHR...

Patent Expiration Date : 2031-10-30

Product Web Link

Corporate PDF

Linaclotide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

12 USDMF

1 JDMF

2 EU WC

6 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers

8 FDA Orange Book

8 Europe

3 Canada

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 145MCG

CAPSULE;ORAL - 290MCG

CAPSULE;ORAL - 72MCG

RELATED EXCIPIENT COMPANIES

1 Evonik

1 SPI Pharma

6 DKSH

2 Gangwal Healthcare

1 Pfanstiehl

4 ACG Worldwide

1 Actylis

1 Aeon Procare

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

10 Corel Pharma Chem

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

17 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Novo Excipients

1 Pharmatrans-Sanaq

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

9 Roquette

6 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

2 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives

23 Controlled & Modified Release

22 Fillers, Diluents & Binders

13 Thickeners and Stabilizers

9 Empty Capsules

9 Direct Compression

7 Granulation

7 Film Formers & Plasticizers

6 Disintegrants & Superdisintegrants

5 Taste Masking

5 Co-Processed Excipients

4 Vegetarian Capsules

4 API Stability Enhancers

4 Coloring Agents

4 Parenteral

4 Lubricants & Glidants

3 Chewable & Orodispersible Aids

2 Rheology Modifiers

1 Solubilizers

1 Emulsifying Agents

1 Topical

DIGITAL CONTENT

45 NEWS #PharmaBuzz